The global Cervical Patch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

From a downstream perspective, Online Sales accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Cervical Patch leading manufacturers including D.FENSTEC, ASPERCREME, ICY HOT, HiTech Therapy, Haleon, Henan Sanhe Pharmaceutical, Beijing Tongrentang, Renhe Group, China National Pharmaceutical Group, Xiuzheng Pharmaceutical Group, etc., dominate supply; the top five capture approximately % of global revenue, with D.FENSTEC leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Cervical Patch market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Cervical Patch Market Report

Report Metric	Details
Report Name	Cervical Patch Market
Segment by Type	Magnetic Therapy Cervical Patch Herbal Cervical Patch Others
Segment by Application	Online Sales Offline Sales
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	D.FENSTEC, ASPERCREME, ICY HOT, HiTech Therapy, Haleon, Henan Sanhe Pharmaceutical, Beijing Tongrentang, Renhe Group, China National Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Guangzhou Pharmaceutical Holdings, Guangdong Kanglong Biotechnology, Shanghai Fosun Pharmaceutical, Huayao Pharmaceutical, Nanyang Xiancao Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Cervical Patch study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Cervical Patch Market report?

Ans: The main players in the Cervical Patch Market are D.FENSTEC, ASPERCREME, ICY HOT, HiTech Therapy, Haleon, Henan Sanhe Pharmaceutical, Beijing Tongrentang, Renhe Group, China National Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Guangzhou Pharmaceutical Holdings, Guangdong Kanglong Biotechnology, Shanghai Fosun Pharmaceutical, Huayao Pharmaceutical, Nanyang Xiancao Pharmaceutical

What are the Application segmentation covered in the Cervical Patch Market report?

Ans: The Applications covered in the Cervical Patch Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Cervical Patch Market report?

Ans: The Types covered in the Cervical Patch Market report are Magnetic Therapy Cervical Patch, Herbal Cervical Patch, Others

1 Study Coverage

1.1 Introduction to Cervical Patch: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Cervical Patch Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Magnetic Therapy Cervical Patch

1.2.3 Herbal Cervical Patch

1.2.4 Others

1.3 Market Segmentation by Application

1.3.1 Global Cervical Patch Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Online Sales

1.3.3 Offline Sales

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Cervical Patch Revenue Estimates and Forecasts 2020-2031

2.2 Global Cervical Patch Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Cervical Patch Sales Estimates and Forecasts 2020-2031

2.4 Global Cervical Patch Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Cervical Patch Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Cervical Patch Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Magnetic Therapy Cervical Patch Market Size by Manufacturers

3.5.2 Herbal Cervical Patch Market Size by Manufacturers

3.5.3 Others Market Size by Manufacturers

3.6 Global Cervical Patch Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Cervical Patch Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Cervical Patch Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Cervical Patch Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Cervical Patch Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Cervical Patch Sales and Revenue by Type (2020-2031)

6.4 North America Cervical Patch Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Cervical Patch Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Cervical Patch Sales and Revenue by Type (2020-2031)

7.4 Europe Cervical Patch Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Cervical Patch Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Cervical Patch Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Cervical Patch Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Cervical Patch Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Cervical Patch Sales and Revenue by Type (2020-2031)

9.4 Central and South America Cervical Patch Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Cervical Patch Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Cervical Patch Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Cervical Patch Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Cervical Patch Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 D.FENSTEC

11.1.1 D.FENSTEC Corporation Information

11.1.2 D.FENSTEC Business Overview

11.1.3 D.FENSTEC Cervical Patch Product Models, Descriptions and Specifications

11.1.4 D.FENSTEC Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 D.FENSTEC Cervical Patch Sales by Product in 2024

11.1.6 D.FENSTEC Cervical Patch Sales by Application in 2024

11.1.7 D.FENSTEC Cervical Patch Sales by Geographic Area in 2024

11.1.8 D.FENSTEC Cervical Patch SWOT Analysis

11.1.9 D.FENSTEC Recent Developments

11.2 ASPERCREME

11.2.1 ASPERCREME Corporation Information

11.2.2 ASPERCREME Business Overview

11.2.3 ASPERCREME Cervical Patch Product Models, Descriptions and Specifications

11.2.4 ASPERCREME Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 ASPERCREME Cervical Patch Sales by Product in 2024

11.2.6 ASPERCREME Cervical Patch Sales by Application in 2024

11.2.7 ASPERCREME Cervical Patch Sales by Geographic Area in 2024

11.2.8 ASPERCREME Cervical Patch SWOT Analysis

11.2.9 ASPERCREME Recent Developments

11.3 ICY HOT

11.3.1 ICY HOT Corporation Information

11.3.2 ICY HOT Business Overview

11.3.3 ICY HOT Cervical Patch Product Models, Descriptions and Specifications

11.3.4 ICY HOT Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 ICY HOT Cervical Patch Sales by Product in 2024

11.3.6 ICY HOT Cervical Patch Sales by Application in 2024

11.3.7 ICY HOT Cervical Patch Sales by Geographic Area in 2024

11.3.8 ICY HOT Cervical Patch SWOT Analysis

11.3.9 ICY HOT Recent Developments

11.4 HiTech Therapy

11.4.1 HiTech Therapy Corporation Information

11.4.2 HiTech Therapy Business Overview

11.4.3 HiTech Therapy Cervical Patch Product Models, Descriptions and Specifications

11.4.4 HiTech Therapy Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 HiTech Therapy Cervical Patch Sales by Product in 2024

11.4.6 HiTech Therapy Cervical Patch Sales by Application in 2024

11.4.7 HiTech Therapy Cervical Patch Sales by Geographic Area in 2024

11.4.8 HiTech Therapy Cervical Patch SWOT Analysis

11.4.9 HiTech Therapy Recent Developments

11.5 Haleon

11.5.1 Haleon Corporation Information

11.5.2 Haleon Business Overview

11.5.3 Haleon Cervical Patch Product Models, Descriptions and Specifications

11.5.4 Haleon Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Haleon Cervical Patch Sales by Product in 2024

11.5.6 Haleon Cervical Patch Sales by Application in 2024

11.5.7 Haleon Cervical Patch Sales by Geographic Area in 2024

11.5.8 Haleon Cervical Patch SWOT Analysis

11.5.9 Haleon Recent Developments

11.6 Henan Sanhe Pharmaceutical

11.6.1 Henan Sanhe Pharmaceutical Corporation Information

11.6.2 Henan Sanhe Pharmaceutical Business Overview

11.6.3 Henan Sanhe Pharmaceutical Cervical Patch Product Models, Descriptions and Specifications

11.6.4 Henan Sanhe Pharmaceutical Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Henan Sanhe Pharmaceutical Recent Developments

11.7 Beijing Tongrentang

11.7.1 Beijing Tongrentang Corporation Information

11.7.2 Beijing Tongrentang Business Overview

11.7.3 Beijing Tongrentang Cervical Patch Product Models, Descriptions and Specifications

11.7.4 Beijing Tongrentang Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Beijing Tongrentang Recent Developments

11.8 Renhe Group

11.8.1 Renhe Group Corporation Information

11.8.2 Renhe Group Business Overview

11.8.3 Renhe Group Cervical Patch Product Models, Descriptions and Specifications

11.8.4 Renhe Group Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Renhe Group Recent Developments

11.9 China National Pharmaceutical Group

11.9.1 China National Pharmaceutical Group Corporation Information

11.9.2 China National Pharmaceutical Group Business Overview

11.9.3 China National Pharmaceutical Group Cervical Patch Product Models, Descriptions and Specifications

11.9.4 China National Pharmaceutical Group Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 China National Pharmaceutical Group Recent Developments

11.10 Xiuzheng Pharmaceutical Group

11.10.1 Xiuzheng Pharmaceutical Group Corporation Information

11.10.2 Xiuzheng Pharmaceutical Group Business Overview

11.10.3 Xiuzheng Pharmaceutical Group Cervical Patch Product Models, Descriptions and Specifications

11.10.4 Xiuzheng Pharmaceutical Group Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Xiuzheng Pharmaceutical Group Recent Developments

11.11 Guangzhou Pharmaceutical Holdings

11.11.1 Guangzhou Pharmaceutical Holdings Corporation Information

11.11.2 Guangzhou Pharmaceutical Holdings Business Overview

11.11.3 Guangzhou Pharmaceutical Holdings Cervical Patch Product Models, Descriptions and Specifications

11.11.4 Guangzhou Pharmaceutical Holdings Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Guangzhou Pharmaceutical Holdings Recent Developments

11.12 Guangdong Kanglong Biotechnology

11.12.1 Guangdong Kanglong Biotechnology Corporation Information

11.12.2 Guangdong Kanglong Biotechnology Business Overview

11.12.3 Guangdong Kanglong Biotechnology Cervical Patch Product Models, Descriptions and Specifications

11.12.4 Guangdong Kanglong Biotechnology Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Guangdong Kanglong Biotechnology Recent Developments

11.13 Shanghai Fosun Pharmaceutical

11.13.1 Shanghai Fosun Pharmaceutical Corporation Information

11.13.2 Shanghai Fosun Pharmaceutical Business Overview

11.13.3 Shanghai Fosun Pharmaceutical Cervical Patch Product Models, Descriptions and Specifications

11.13.4 Shanghai Fosun Pharmaceutical Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Shanghai Fosun Pharmaceutical Recent Developments

11.14 Huayao Pharmaceutical

11.14.1 Huayao Pharmaceutical Corporation Information

11.14.2 Huayao Pharmaceutical Business Overview

11.14.3 Huayao Pharmaceutical Cervical Patch Product Models, Descriptions and Specifications

11.14.4 Huayao Pharmaceutical Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 Huayao Pharmaceutical Recent Developments

11.15 Nanyang Xiancao Pharmaceutical

11.15.1 Nanyang Xiancao Pharmaceutical Corporation Information

11.15.2 Nanyang Xiancao Pharmaceutical Business Overview

11.15.3 Nanyang Xiancao Pharmaceutical Cervical Patch Product Models, Descriptions and Specifications

11.15.4 Nanyang Xiancao Pharmaceutical Cervical Patch Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 Nanyang Xiancao Pharmaceutical Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Cervical Patch Industry Chain

12.2 Cervical Patch Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Cervical Patch Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Cervical Patch Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Cervical Patch Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Cervical Patch Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Henan Sanhe Pharmaceutical

Beijing Tongrentang

Renhe Group

China National Pharmaceutical Group

Xiuzheng Pharmaceutical Group

Guangzhou Pharmaceutical Holdings

Shanghai Fosun Pharmaceutical

Huayao Pharmaceutical

Nanyang Xiancao Pharmaceutical

D.FENSTEC

Guangdong Kanglong Biotechnology

List of Tables

Table 1. Global Cervical Patch Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Cervical Patch Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Cervical Patch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Cervical Patch Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Cervical Patch Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Cervical Patch Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Cervical Patch Sales by Region (2020-2025) & (K Units)

Table 8. Global Cervical Patch Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Cervical Patch Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Cervical Patch Sales Share by Manufacturers (2020-2025)

Table 12. Global Cervical Patch Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Cervical Patch Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Cervical Patch by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cervical Patch as of 2024)

Table 16. Global Cervical Patch Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Cervical Patch Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Cervical Patch Manufacturing Base and Headquarters

Table 19. Global Cervical Patch Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Cervical Patch Sales by Type (2020-2025) & (K Units)

Table 23. Global Cervical Patch Sales by Type (2026-2031) & (K Units)

Table 24. Global Cervical Patch Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Cervical Patch Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Cervical Patch ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Cervical Patch Sales by Application (2020-2025) & (K Units)

Table 29. Global Cervical Patch Sales by Application (2026-2031) & (K Units)

Table 30. Cervical Patch High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Cervical Patch Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Cervical Patch Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Cervical Patch ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Cervical Patch Growth Accelerators and Market Barriers

Table 37. North America Cervical Patch Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Cervical Patch Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Cervical Patch Growth Accelerators and Market Barriers

Table 40. Europe Cervical Patch Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Cervical Patch Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Cervical Patch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Cervical Patch Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Cervical Patch Growth Accelerators and Market Barriers

Table 45. Southeast Asia Cervical Patch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Cervical Patch Investment Opportunities and Key Challenges

Table 47. Central and South America Cervical Patch Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Cervical Patch Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Cervical Patch Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. D.FENSTEC Corporation Information

Table 51. D.FENSTEC Description and Major Businesses

Table 52. D.FENSTEC Product Models, Descriptions and Specifications

Table 53. D.FENSTEC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. D.FENSTEC Sales Value Proportion by Product in 2024

Table 55. D.FENSTEC Sales Value Proportion by Application in 2024

Table 56. D.FENSTEC Sales Value Proportion by Geographic Area in 2024

Table 57. D.FENSTEC Cervical Patch SWOT Analysis

Table 58. D.FENSTEC Recent Developments

Table 59. ASPERCREME Corporation Information

Table 60. ASPERCREME Description and Major Businesses

Table 61. ASPERCREME Product Models, Descriptions and Specifications

Table 62. ASPERCREME Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. ASPERCREME Sales Value Proportion by Product in 2024

Table 64. ASPERCREME Sales Value Proportion by Application in 2024

Table 65. ASPERCREME Sales Value Proportion by Geographic Area in 2024

Table 66. ASPERCREME Cervical Patch SWOT Analysis

Table 67. ASPERCREME Recent Developments

Table 68. ICY HOT Corporation Information

Table 69. ICY HOT Description and Major Businesses

Table 70. ICY HOT Product Models, Descriptions and Specifications

Table 71. ICY HOT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. ICY HOT Sales Value Proportion by Product in 2024

Table 73. ICY HOT Sales Value Proportion by Application in 2024

Table 74. ICY HOT Sales Value Proportion by Geographic Area in 2024

Table 75. ICY HOT Cervical Patch SWOT Analysis

Table 76. ICY HOT Recent Developments

Table 77. HiTech Therapy Corporation Information

Table 78. HiTech Therapy Description and Major Businesses

Table 79. HiTech Therapy Product Models, Descriptions and Specifications

Table 80. HiTech Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. HiTech Therapy Sales Value Proportion by Product in 2024

Table 82. HiTech Therapy Sales Value Proportion by Application in 2024

Table 83. HiTech Therapy Sales Value Proportion by Geographic Area in 2024

Table 84. HiTech Therapy Cervical Patch SWOT Analysis

Table 85. HiTech Therapy Recent Developments

Table 86. Haleon Corporation Information

Table 87. Haleon Description and Major Businesses

Table 88. Haleon Product Models, Descriptions and Specifications

Table 89. Haleon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Haleon Sales Value Proportion by Product in 2024

Table 91. Haleon Sales Value Proportion by Application in 2024

Table 92. Haleon Sales Value Proportion by Geographic Area in 2024

Table 93. Haleon Cervical Patch SWOT Analysis

Table 94. Haleon Recent Developments

Table 95. Henan Sanhe Pharmaceutical Corporation Information

Table 96. Henan Sanhe Pharmaceutical Description and Major Businesses

Table 97. Henan Sanhe Pharmaceutical Product Models, Descriptions and Specifications

Table 98. Henan Sanhe Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Henan Sanhe Pharmaceutical Recent Developments

Table 100. Beijing Tongrentang Corporation Information

Table 101. Beijing Tongrentang Description and Major Businesses

Table 102. Beijing Tongrentang Product Models, Descriptions and Specifications

Table 103. Beijing Tongrentang Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Beijing Tongrentang Recent Developments

Table 105. Renhe Group Corporation Information

Table 106. Renhe Group Description and Major Businesses

Table 107. Renhe Group Product Models, Descriptions and Specifications

Table 108. Renhe Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Renhe Group Recent Developments

Table 110. China National Pharmaceutical Group Corporation Information

Table 111. China National Pharmaceutical Group Description and Major Businesses

Table 112. China National Pharmaceutical Group Product Models, Descriptions and Specifications

Table 113. China National Pharmaceutical Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. China National Pharmaceutical Group Recent Developments

Table 115. Xiuzheng Pharmaceutical Group Corporation Information

Table 116. Xiuzheng Pharmaceutical Group Description and Major Businesses

Table 117. Xiuzheng Pharmaceutical Group Product Models, Descriptions and Specifications

Table 118. Xiuzheng Pharmaceutical Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Xiuzheng Pharmaceutical Group Recent Developments

Table 120. Guangzhou Pharmaceutical Holdings Corporation Information

Table 121. Guangzhou Pharmaceutical Holdings Description and Major Businesses

Table 122. Guangzhou Pharmaceutical Holdings Product Models, Descriptions and Specifications

Table 123. Guangzhou Pharmaceutical Holdings Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Guangzhou Pharmaceutical Holdings Recent Developments

Table 125. Guangdong Kanglong Biotechnology Corporation Information

Table 126. Guangdong Kanglong Biotechnology Description and Major Businesses

Table 127. Guangdong Kanglong Biotechnology Product Models, Descriptions and Specifications

Table 128. Guangdong Kanglong Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Guangdong Kanglong Biotechnology Recent Developments

Table 130. Shanghai Fosun Pharmaceutical Corporation Information

Table 131. Shanghai Fosun Pharmaceutical Description and Major Businesses

Table 132. Shanghai Fosun Pharmaceutical Product Models, Descriptions and Specifications

Table 133. Shanghai Fosun Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. Shanghai Fosun Pharmaceutical Recent Developments

Table 135. Huayao Pharmaceutical Corporation Information

Table 136. Huayao Pharmaceutical Description and Major Businesses

Table 137. Huayao Pharmaceutical Product Models, Descriptions and Specifications

Table 138. Huayao Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 139. Huayao Pharmaceutical Recent Developments

Table 140. Nanyang Xiancao Pharmaceutical Corporation Information

Table 141. Nanyang Xiancao Pharmaceutical Description and Major Businesses

Table 142. Nanyang Xiancao Pharmaceutical Product Models, Descriptions and Specifications

Table 143. Nanyang Xiancao Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 144. Nanyang Xiancao Pharmaceutical Recent Developments

Table 145. Key Raw Materials Distribution

Table 146. Raw Materials Key Suppliers

Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 148. Milestones in Production Technology Evolution

Table 149. Distributors List

Table 150. Market Trends and Market Evolution

Table 151. Market Drivers and Opportunities

Table 152. Market Challenges, Risks, and Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Cervical Patch Product Picture

Figure 2. Global Cervical Patch Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Magnetic Therapy Cervical Patch Product Picture

Figure 4. Herbal Cervical Patch Product Picture

Figure 5. Others Product Picture

Figure 6. Global Cervical Patch Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Online Sales

Figure 8. Offline Sales

Figure 9. Cervical Patch Report Years Considered

Figure 10. Global Cervical Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 12. Global Cervical Patch Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Cervical Patch Revenue Market Share by Region (2020-2031)

Figure 14. Global Cervical Patch Sales (2020-2031) & (K Units)

Figure 15. Global Cervical Patch Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global Cervical Patch Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Cervical Patch Sales Volume Market Share in 2024

Figure 18. Global Cervical Patch Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Magnetic Therapy Cervical Patch Revenue Market Share by Manufacturer in 2024

Figure 21. Herbal Cervical Patch Revenue Market Share by Manufacturer in 2024

Figure 22. Others Revenue Market Share by Manufacturer in 2024

Figure 23. Global Cervical Patch Sales Market Share by Type (2020-2031)

Figure 24. Global Cervical Patch Revenue Market Share by Type (2020-2031)

Figure 25. Global Cervical Patch Sales Market Share by Application (2020-2031)

Figure 26. Global Cervical Patch Revenue Market Share by Application (2020-2031)

Figure 27. North America Cervical Patch Sales YoY (2020-2031) & (K Units)

Figure 28. North America Cervical Patch Revenue YoY (2020-2031) & (US$ Million)

Figure 29. North America Top 5 Manufacturers Cervical Patch Sales Revenue (US$ Million) in 2024

Figure 30. North America Cervical Patch Sales Volume (K Units) by Type (2020- 2031)

Figure 31. North America Cervical Patch Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 32. North America Cervical Patch Sales Volume (K Units) by Application (2020-2031)

Figure 33. North America Cervical Patch Sales Revenue (US$ Million) by Application (2020-2031)

Figure 34. US Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 35. Canada Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 36. Mexico Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 37. Europe Cervical Patch Sales YoY (2020-2031) & (K Units)

Figure 38. Europe Cervical Patch Revenue YoY (2020-2031) & (US$ Million)

Figure 39. Europe Top 5 Manufacturers Cervical Patch Sales Revenue (US$ Million) in 2024

Figure 40. Europe Cervical Patch Sales Volume (K Units) by Type (2020-2031)

Figure 41. Europe Cervical Patch Sales Revenue (US$ Million) by Type (2020-2031)

Figure 42. Europe Cervical Patch Sales Volume (K Units) by Application (2020-2031)

Figure 43. Europe Cervical Patch Sales Revenue (US$ Million) by Application (2020-2031)

Figure 44. Germany Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 45. France Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 46. U.K. Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 47. Italy Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 48. Russia Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 49. Asia-Pacific Cervical Patch Sales YoY (2020-2031) & (K Units)

Figure 50. Asia-Pacific Cervical Patch Revenue YoY (2020-2031) & (US$ Million)

Figure 51. Asia-Pacific Top 8 Manufacturers Cervical Patch Sales Revenue (US$ Million) in 2024

Figure 52. Asia-Pacific Cervical Patch Sales Volume (K Units) by Type (2020- 2031)

Figure 53. Asia-Pacific Cervical Patch Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 54. Asia-Pacific Cervical Patch Sales Volume (K Units) by Application (2020-2031)

Figure 55. Asia-Pacific Cervical Patch Sales Revenue (US$ Million) by Application (2020-2031)

Figure 56. Indonesia Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 57. Japan Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 58. South Korea Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 59. China Taiwan Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 60. India Cervical Patch Revenue (2020-2031) & (US$ Million)

Figure 61. Central and South America Cervical Patch Sales YoY (2020-2031) & (K Units)

Figure 62. Central and South America Cervical Patch Revenue YoY (2020-2031) & (US$ Million)

Figure 63. Central and South America Top 5 Manufacturers Cervical Patch Sales Revenue (US$ Million) in 2024

Figure 64. Central and South America Cervical Patch Sales Volume (K Units) by Type (2021-2031)

Figure 65. Central and South America Cervical Patch Sales Revenue (US$ Million) by Type (2020-2031)

Figure 66. Central and South America Cervical Patch Sales Volume (K Units) by Application (2020-2031)

Figure 67. Central and South America Cervical Patch Sales Revenue (US$ Million) by Application (2020-2031)

Figure 68. Brazil Cervical Patch Revenue (2020-2025) & (US$ Million)

Figure 69. Argentina Cervical Patch Revenue (2020-2025) & (US$ Million)

Figure 70. Middle East, and Africa Cervical Patch Sales YoY (2020-2031) & (K Units)

Figure 71. Middle East and Africa Cervical Patch Revenue YoY (2020-2031) & (US$ Million)

Figure 72. Middle East and Africa Top 5 Manufacturers Cervical Patch Sales Revenue (US$ Million) in 2024

Figure 73. Middle East and Africa Cervical Patch Sales Volume (K Units) by Type (2021-2031)

Figure 74. South America Cervical Patch Sales Revenue (US$ Million) by Type (2020-2031)

Figure 75. Middle East and Africa Cervical Patch Sales Volume (K Units) by Application (2020-2031)

Figure 76. Middle East and Africa Cervical Patch Sales Revenue (US$ Million) by Application (2020-2031)

Figure 77. GCC Countries Cervical Patch Revenue (2020-2025) & (US$ Million)

Figure 78. Turkey Cervical Patch Revenue (2020-2025) & (US$ Million)

Figure 79. Egypt Cervical Patch Revenue (2020-2025) & (US$ Million)

Figure 80. South Africa Cervical Patch Revenue (2020-2025) & (US$ Million)

Figure 81. Cervical Patch Industry Chain Mapping

Figure 82. Regional Cervical Patch Manufacturing Base Distribution (%)

Figure 83. Global Cervical Patch Production Market Share by Region (2020-2031)

Figure 84. Cervical Patch Production Process

Figure 85. Regional Cervical Patch Production Cost Structure

Figure 86. Channels of Distribution (Direct Vs Distribution)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions